Assessing FOXO1A as a potential susceptibility locus for type 2 diabetes and obesity in American Indians

Abstract

Objective A prior genome-wide association study (GWAS) in Pima Indians identified variation within FOXO1A that modestly associated with early-onset (onset age <25years) type 2 diabetes (T2D). FOXO1A encodes the forkhead transcription factor involved in pancreatic β-cell growth and hypothalamic energy balance; therefore, FOXO1A was analyzed as a candidate gene for T2D and obesity in a population-based sample of 7,710 American Indians. Methods Tag SNPs in/near FOXO1A (minor allele frequency≥0.05) were analyzed for association with T2D at early onset (n = 1,060) and all ages (n = 7,710) and with insulin secretion (n = 298). SNPs were also analyzed for association with maximum body mass index (BMI) in adulthood (n = 5,918), maximum BMI z-score in childhood (n = 5,350), and % body fat (n = 555). Results An intronic SNP rs2297627 associated with early-onset T2D [OR = 1.34 (1.13-1.58), P = 8.7 × 10-4] and T2D onset at any age [OR = 1.19 (1.09-1.30), P = 1 × 10-4]. The T2D risk allele also associated with lower acute insulin secretion (β = 0.88, as a multiplier, P = 0.02). Another intronic SNP (rs1334241, D′ = 0.99, r2 = 0.49 with rs2297627) associated with maximum adulthood BMI (β = 1.02, as a multiplier, P = 3 × 10-5), maximum childhood BMI z-score (β = 0.08, P = 3 × 10-4), and % body fat (β = 0.83%, P = 0.04). Conclusions Common variation in FOXO1A may modestly affect risk for T2D and obesity in American Indians.